Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Bipolar disorder is characterized by mood fluctuations.
• Rapid cycling bipolar disorder presents a more severe subtype with frequent mood state changes.
• Neurobiological underpinnings of rapid cycling require further elucidation.

Purpose of the Study:

• To investigate alterations in brain metabolites in patients with bipolar II rapid cycling (RC).
• To compare metabolite levels in RC patients with non-rapid cycling bipolar disorder (BIPD) and healthy controls (HC).
• To explore the potential role of glutamate/glutamine (Glx) as a marker of cortical activity in RC.

Main Methods:

• Proton magnetic resonance spectroscopy (MRS) was used to assess metabolites in the left dorsolateral prefrontal cortex (DLPFC).
• Participants included six RC patients, six BIPD patients, and six HC.
• Metabolite levels were measured across depressed, hypomanic, and euthymic mood states.

Main Results:

• RC patients exhibited elevated levels of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and glutamate/glutamine (Glx) compared to BIPD and HC.
• Glx levels did not differ significantly between BIPD and HC.
• Other metabolites were increased in BIPD compared to HC, but to a lesser extent than in RC patients.

Conclusions:

• Elevated brain metabolites, particularly Glx, in RC patients suggest increased neuronal activity.
• Increased cortical activity may be a significant neurobiological characteristic of rapid cycling bipolar disorder.
• These findings contribute to understanding the neurobiology of severe bipolar disorder subtypes.